About
Copy Link
Titles
Statistician 2
Departments & Organizations
Education & Training
- MPH
- Yale School of Public Health (2014)
- PhD
- Huazhong University of Science and Technology (2008)
Research
Copy Link
Research at a Glance
Yale Co-Authors
Frequent collaborators of Geliang Gan's published research.
Publications Timeline
A big-picture view of Geliang Gan's research output by year.
Fangyong Li, MS, MPH
Brinda Emu, MD
Elijah Paintsil, FAAP, MD
James Dziura, MPH, PhD
Jeremy Kortmansky, MD
Keith Choate, MD, PhD
57Publications
708Citations
Publications
2025
Changes in caregiver psychosocial factors known to affect pediatric HIV disclosure: the Sankofa clinical trial experience in Ghana (2013–2023)
Afrane A, Bobbala A, Martyn-Dickens C, Renner L, Antwi S, Kusah J, Amissah K, Quaye D, Bosomtwe D, Gan G, Parziale S, Reynolds N, Paintsil E, Shabanova V, Team O. Changes in caregiver psychosocial factors known to affect pediatric HIV disclosure: the Sankofa clinical trial experience in Ghana (2013–2023). AIDS Care 2025, ahead-of-print: 1-16. PMID: 41330401, DOI: 10.1080/09540121.2025.2594607.Peer-Reviewed Original ResearchConceptsPediatric HIV disclosureIllness perceptionsHIV disclosureHIV knowledgePsychosocial domainsSocial supportHIV statusCaregiver psychosocial factorsCaregiver-related factorsChild's HIV statusChildren Aged 7Earning higher incomeMultivariate linear regressionCaregiver characteristicsHIV stigmaHigh stigmaPsychosocial factorsCaregiversStructured questionnaireHigher incomeBaseline dataStigmaAged 7Younger ageHIVScale-up of a paediatric HIV disclosure intervention in Ghana using a stepped wedge cluster randomised trial design: Sankofa 2 protocol and implementation
Reynolds N, Shabanova V, Renner L, Antwi S, Addo S, Enimil A, Lartey M, Gan G, Parziale S, Amissah K, Kusah J, Ofori-Atta A, Slade E, Agyarko-Poku T, Paintsil E. Scale-up of a paediatric HIV disclosure intervention in Ghana using a stepped wedge cluster randomised trial design: Sankofa 2 protocol and implementation. BMJ Open 2025, 15: e099681. PMID: 41238360, PMCID: PMC12625916, DOI: 10.1136/bmjopen-2025-099681.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsHIV disclosure interventionsDisclosure interventionGhana Health Service Ethical Review CommitteeStepped-wedge cluster randomised trialCluster randomised trial designCluster randomised trialReview CommitteeRandomised trial designHealth benefitsCaregiver-child dyadsPeer-reviewed journalsCaregiver participationProtocol Review CommitteeYale SchoolEthics Review CommitteeHuman Investigation CommitteeEffective interventionsHealthcare workersHIV statusPaediatric clinicsCaregiversEthical clearanceFollow-up studyWritten Informed ConsentEvaluation of effectiveness156 Prevalence and Severity of Ectropion Among Epidermal Differentiation Disorders
Luo A, Echeandia-Francis C, Jiang X, Ellis K, Mani M, Chen T, Gan G, Deng Y, Choate K. 156 Prevalence and Severity of Ectropion Among Epidermal Differentiation Disorders. Journal Of Investigative Dermatology 2025, 145: e56. DOI: 10.1016/j.jid.2025.09.171.Peer-Reviewed Original ResearchCover Image, Volume 39, Issue 5
Sapir‐Pichhadze R, Askar M, Cooper M, Cornell L, Cozzi E, Dadhania D, Diekmann F, de Vries A, Schinstock C, Carroll R, Abdelrehim A, Gan G, Deng Y, Alasfar S, Bagnasco S, Batal I, Budde K, Groningen M, Kung V, Lower F, Seija M, Kraus E, Naesens M, Bow L, Group T. Cover Image, Volume 39, Issue 5. Clinical Transplantation 2025, 39 DOI: 10.1111/ctr.70184.Peer-Reviewed Original ResearchRethinking the Diagnosis and Management of Antibody‐Mediated Rejection in Multidisciplinary Transplant Meetings: A Global Survey and Banff Working Group Recommendations
Sapir‐Pichhadze R, Askar M, Cooper M, Cornell L, Cozzi E, Dadhania D, Diekmann F, de Vries A, Schinstock C, Carroll R, Abdelrehim A, Gan G, Deng Y, Alasfar S, Bagnasco S, Batal I, Budde K, Groningen M, Kung V, Lower F, Seija M, Kraus E, Naesens M, Bow L, Group T. Rethinking the Diagnosis and Management of Antibody‐Mediated Rejection in Multidisciplinary Transplant Meetings: A Global Survey and Banff Working Group Recommendations. Clinical Transplantation 2025, 39: e70167. PMID: 40294134, PMCID: PMC12036956, DOI: 10.1111/ctr.70167.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsAntibody-mediated rejectionMultidisciplinary meetingDiagnosis of antibody-mediated rejectionManagement of antibody-mediated rejectionAntibody-mediated rejection diagnosisTransplant recipientsDiagnosis revisionPatient characteristicsAcademic centersTransplant meetingsCase presentationTransplant professionalsTransplantationStandard careWorking group recommendationsTransplant programsAntibody dataDiagnosisLaboratory expertsMolecular diagnosticsImprove careTrainee educationMedical educationBanffPrimary barrierCase series of black athletes participating in sports with an implantable cardioverter-defibrillator: Data from the ICD Sports Registry
Chukumerije M, Olshansky B, Saarel E, Cannom D, Link M, Ackerman M, Gan G, Lampert R. Case series of black athletes participating in sports with an implantable cardioverter-defibrillator: Data from the ICD Sports Registry. Heart Rhythm O2 2025, 6: 1044-1046. PMID: 40734739, PMCID: PMC12302195, DOI: 10.1016/j.hroo.2025.04.008.Peer-Reviewed Original Research
2024
Correction: Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study
Bade B, Gan G, Li F, Lu L, Tanoue L, Silvestri G, Irwin M. Correction: Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study. BMC Cancer 2024, 24: 1409. PMID: 39548453, PMCID: PMC11566398, DOI: 10.1186/s12885-024-13183-9.Peer-Reviewed Original ResearchCitationsAltmetricPsychosocial Evaluation of Living Kidney Donors: A Survey of Current Practices in the United States
Clifton E, Winder G, Lentine K, Zimbrean P, Yadav A, Rubman S, Kalil R, Kumar V, Prashar R, Gan G, Deng Y, Joyce M, Holmes R, Laflen J, Bakhai D, Liapakis A, Doshi M. Psychosocial Evaluation of Living Kidney Donors: A Survey of Current Practices in the United States. Transplantation 2024, 108: e382-e389. PMID: 38867351, DOI: 10.1097/tp.0000000000005095.Peer-Reviewed Original ResearchCitationsAltmetricConceptsSubstance use disordersUse disorderActive anxiety disorderMental healthPosttraumatic stress disorderPsychosocial teamAnxiety disordersStress disorderActive suicidalitySelf-harmActivity depressionDisordersPsychosocial assessmentDepressionPsychosocial evaluationPost-donationUnited StatesClinical toolPsychosisLiving Kidney DonorsCannabisAnxietySuicideAbsolute contraindicationBest practicesIn‐person validation of the Ichthyosis Scoring System
Echeandia‐Francis C, Sun Q, Asch S, Bayart C, Benjamin L, Cipriano S, Craiglow B, Dyer J, Levy M, Lilly E, Newell B, Liang J, Gan G, Deng Y, Paller A, Choate K. In‐person validation of the Ichthyosis Scoring System. Pediatric Dermatology 2024, 41: 247-252. PMID: 38234066, DOI: 10.1111/pde.15508.Peer-Reviewed Original ResearchCitationsAltmetricConceptsInterrater intraclass correlation coefficientsIntrarater reliabilityIn-personIntraclass correlation coefficientIn-person evaluationContent validityInterrater reliabilityHeterogeneous group of skin disordersGroup of skin disordersIntraraterMedical professionalsInterrater agreementErythema evaluationIchthyosis subtypesPhotographic evaluationErythema scoreInterraterErythemaQuantify severitySkin disordersClinical utilityIchthyosisScoring systemHeterogeneous groupCorrelation coefficient
2023
Pediatric HIV Disclosure Intervention Improves Immunologic Outcome at 48 Weeks: The Sankofa Trial Experience
Shabanova V, Emuren L, Gan G, Antwi S, Renner L, Amissah K, Kusah J, Lartey M, Reynolds N, Paintsil E. Pediatric HIV Disclosure Intervention Improves Immunologic Outcome at 48 Weeks: The Sankofa Trial Experience. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2023, 94: 371-380. PMID: 37643414, PMCID: PMC10617661, DOI: 10.1097/qai.0000000000003292.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsHIV disclosure interventionsVirologic outcomesCD4 percentWeek 48HIV statusIntervention groupHIV disclosureDisclosure interventionDetectable viral loadWorld Health OrganizationAntiretroviral therapyImmunologic outcomesClinical outcomesIntervention armViral loadControl armClinical trialsTrial experienceSecondary analysisDisclosure statusHealth OrganizationCategorical variablesWeeksLinear mixed modelsBaseline
News
Copy Link
Get In Touch
Copy Link
Contacts
Email